Pages that link to "Q37512911"
Jump to navigation
Jump to search
The following pages link to Rational combinations using HDAC inhibitors (Q37512911):
Displaying 50 items.
- Epigenetic modifications in cancer (Q22242610) (← links)
- Targeting histone deacetylases for cancer therapy: from molecular mechanisms to clinical implications (Q26853394) (← links)
- Chemopreventive and anti-cancer efficacy of silibinin against growth and progression of lung cancer (Q26998615) (← links)
- Causes and consequences of microRNA dysregulation in cancer (Q28258994) (← links)
- The anti-tumor effect of HDAC inhibition in a human pancreas cancer model is significantly improved by the simultaneous inhibition of cyclooxygenase 2 (Q28533258) (← links)
- Synergistic antitumor effects of novel HDAC inhibitors and paclitaxel in vitro and in vivo (Q28741274) (← links)
- In vitro and in vivo histone deacetylase inhibitor therapy with vorinostat and paclitaxel in ovarian cancer models: Does timing matter? (Q30451470) (← links)
- Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors. (Q33390876) (← links)
- Phase I study of decitabine in combination with vorinostat in patients with advanced solid tumors and non-Hodgkin's lymphomas. (Q33393266) (← links)
- Romidepsin: in the treatment of T-cell lymphoma (Q33396519) (← links)
- A Phase II trial of Belinostat (PXD101) in patients with relapsed or refractory peripheral or cutaneous T-cell lymphoma (Q33418737) (← links)
- Gemtuzumab ozogamicin in combination with vorinostat and azacitidine in older patients with relapsed or refractory acute myeloid leukemia: a phase I/II study (Q33558088) (← links)
- Targeting CD146 in combination with vorinostat for the treatment of ovarian cancer cells (Q33598464) (← links)
- A new gene selection procedure based on the covariance distance (Q33627569) (← links)
- Histone deacetylase inhibitors: a chemical genetics approach to understanding cellular functions (Q33705588) (← links)
- Notch3 overexpression enhances progression and chemoresistance of urothelial carcinoma (Q33798364) (← links)
- The clinical development of histone deacetylase inhibitors as targeted anticancer drugs (Q33829390) (← links)
- HDAC2 attenuates TRAIL-induced apoptosis of pancreatic cancer cells. (Q33842416) (← links)
- The HDAC inhibitor LBH589 (panobinostat) is an inhibitory modulator of aromatase gene expression (Q33934350) (← links)
- Epigenetics and cancer (Q34085532) (← links)
- Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair. (Q34093052) (← links)
- Valproic acid induces differentiation and transient tumor regression, but spares leukemia-initiating activity in mouse models of APL. (Q34254302) (← links)
- Trichostatin A accentuates doxorubicin-induced hypertrophy in cardiac myocytes. (Q34361211) (← links)
- Initial testing (stage 1) of the histone deacetylase inhibitor, quisinostat (JNJ-26481585), by the Pediatric Preclinical Testing Program (Q34371357) (← links)
- Regulation of CRADD-caspase 2 cascade by histone deacetylase 1 in gastric cancer (Q34420590) (← links)
- Sphingosine kinase 1 is required for mesothelioma cell proliferation: role of histone acetylation (Q34428778) (← links)
- Trichostatin A restores Apaf-1 function in chemoresistant ovarian cancer cells (Q34553378) (← links)
- Eradication of solid tumors using histone deacetylase inhibitors combined with immune-stimulating antibodies (Q34652570) (← links)
- Enrichment of Nur77 mediated by retinoic acid receptor β leads to apoptosis of human hepatocellular carcinoma cells induced by fenretinide and histone deacetylase inhibitors (Q34799745) (← links)
- HDAC-inhibitor (S)-8 disrupts HDAC6-PP1 complex prompting A375 melanoma cell growth arrest and apoptosis (Q34885424) (← links)
- Histone deacetylase (HDAC) inhibitory and antiproliferative activities of phenolic-rich extracts derived from the rhizome of Hydnophytum formicarum Jack.: sinapinic acid acts as HDAC inhibitor (Q34992824) (← links)
- Combining the pan-aurora kinase inhibitor AMG 900 with histone deacetylase inhibitors enhances antitumor activity in prostate cancer (Q34998552) (← links)
- DNMT1 stability is regulated by proteins coordinating deubiquitination and acetylation-driven ubiquitination (Q35048728) (← links)
- Thailandepsins: bacterial products with potent histone deacetylase inhibitory activities and broad-spectrum antiproliferative activities. (Q35476003) (← links)
- Histone deacetylase inhibitors globally enhance h3/h4 tail acetylation without affecting h3 lysine 56 acetylation (Q35667942) (← links)
- Rational Combinations of Targeted Agents in AML (Q35750491) (← links)
- A combination of a ribonucleotide reductase inhibitor and histone deacetylase inhibitors downregulates EGFR and triggers BIM-dependent apoptosis in head and neck cancer. (Q35799771) (← links)
- Targeting Histone Deacetylases in Diseases: Where Are We? (Q35821728) (← links)
- Histone deacetylase inhibition sensitizes osteosarcoma to heavy ion radiotherapy (Q35856816) (← links)
- The Therapeutic Potential of AN-7, a Novel Histone Deacetylase Inhibitor, for Treatment of Mycosis Fungoides/Sezary Syndrome Alone or with Doxorubicin (Q35890561) (← links)
- Inhibition of breast cancer progression by a novel histone deacetylase inhibitor, LW479, by down-regulating EGFR expression. (Q35911749) (← links)
- Epigenetic alterations in bladder cancer and their potential clinical implications. (Q36095721) (← links)
- A unique histone deacetylase inhibitor alters microRNA expression and signal transduction in chemoresistant ovarian cancer cells (Q36129967) (← links)
- Romidepsin (FK228) combined with cisplatin stimulates DNA damage-induced cell death in ovarian cancer (Q36521908) (← links)
- Combination therapy: histone deacetylase inhibitors and platinum-based chemotherapeutics for cancer (Q36537920) (← links)
- Butyrate histone deacetylase inhibitors. (Q36574546) (← links)
- Improved therapeutic effect against leukemia by a combination of the histone methyltransferase inhibitor chaetocin and the histone deacetylase inhibitor trichostatin A. (Q36589485) (← links)
- Dysregulation of autophagy in chronic lymphocytic leukemia with the small-molecule Sirtuin inhibitor Tenovin-6. (Q36609978) (← links)
- Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma. (Q36631618) (← links)
- Silibinin synergizes with histone deacetylase and DNA methyltransferase inhibitors in upregulating E-cadherin expression together with inhibition of migration and invasion of human non-small cell lung cancer cells (Q36776566) (← links)